Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome

European Journal of Pain

Volumn 14, Issue 5, 2010, Pages 523-528

  Munts, Alexander G ^a   van der Plas, Anton A ^a   Ferrari, Michel D ^a   Teepe Twiss, Irene M ^a   Marinus, Johan ^a   van Hilten, Jacobus J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Complex regional pain syndrome; Intrathecal; Methylprednisolone; Movement disorders; Neuropathic pain; TREND study

Indexed keywords

METHYLPREDNISOLONE ACETATE; PLACEBO; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BACKACHE; BOLUS INJECTION; CHRONIC PAIN; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECUBITUS; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; EDEMA; FEMALE; FLUSHING; FOLLOW UP; HUMAN; IMMUNOSTIMULATION; MAJOR DEPRESSION; MALE; POSTDURAL PUNCTURE HEADACHE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; SINGLE DRUG DOSE; SKIN ODOR; SYNCOPE; TENSION HEADACHE; TREND STUDY; UNSPECIFIED SIDE EFFECT;

ADULT; ANALYSIS OF VARIANCE; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS, SPINAL; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SELECTION; QUALITY OF LIFE; REFLEX SYMPATHETIC DYSTROPHY; TREATMENT OUTCOME;

EID: 77951877434     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2009.11.004     Document Type: Article

References (62)

1. Abel Jr. R., Nelson D.A., and Bernat J.L. Complications from methylprednisolone acetate (Depo-Medrol) when injected into the orbit, subarachnoid, or subdural spaces. Del Med J 49 (1977) 331-343
2. Abram S.E. Letter to the editor "Perceived dangers from intraspinal steroid injections". Arch Neurol 46 (1989) 719-720
3. 2 selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons. Nat Neurosci 5 (2002) 34-40
4. Alexander G.M., van Rijn M.A., van Hilten J.J., Perreault M.J., and Schwartzman R.J. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain 116 (2005) 213-219
5. Bellhouse C.P., Watson J.R., Farrow M.A., and Ulyatt. Letter to the editor. Med J Aust 1 (1982) 11
6. Bernat J.L., Sadowsky C.H., Vincent F.M., Nordgren R.E., and Margolis G. Sclerosing spinal pachymeningitis. A complication of intrathecal administration of Depo-Medrol for multiple sclerosis. J Neurol Neurosurg Psychiatry 39 (1976) 1124-1128
7. Birklein F., and Schmelz M. Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett 437 (2008) 199-202
8. Bradley K.C., Corrigan A.B., and Ingpen M.L. Letter to the editor. Med J Aust 1 (1982) 11-12
9. Burke R.E., Fahn S., Marsden C.D., Bressman S.B., Moskowitz C., and Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35 (1985) 73-77
10. Carta F., Canu C., Datti R., Guiducci G., Pisani R., and Silvestro C. Calcification and ossification of the spinal arachnoid after intrathecal administration of Depo-Medrol. Zentralbl Neurochir 48 (1987) 256-261
11. Chernow B., Vigersky R., O'Brian J.T., and Georges L.P. Secondary adrenal insufficiency after intrathecal steroid administration. J Neurosurg 56 (1982) 567-570
12. Cohen F.L. Conus medullaris syndrome following multiple intrathecal corticosteroid injections. Arch Neurol 36 (1979) 228-230
13. Dewey P. Letter to the editor. Med J Aust 1 (1982) 9
14. Dougherty Jr. J.H., and Fraser R.A. Complications following intraspinal injections of steroids. Report of two cases. J Neurosurg 48 (1978) 1023-1025
15. Edwards W.T. Comment on "Intrathecal Depo-Medrol". Clin J Pain 8 (1992) 57-58
16. Farrar J.T., Young Jr. J.P., LaMoreaux L., Werth J.L., and Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94 (2001) 149-158
17. Ferguson A.R., Crown E.D., and Grau J.W. Nociceptive plasticity inhibits adaptive learning in the spinal cord. Neuroscience 141 (2006) 421-431
18. Fisher D., Stewart A.L., Bloch D.A., Lorig K., Laurent D., and Holman H. Capturing the patient's view of change as a clinical outcome measure. JAMA 282 (1999) 1157-1162
19. Frucht S.J., Leurgans S.E., Hallett M., and Fahn S. The unified myoclonus rating scale. Adv Neurol 89 (2002) 361-376
20. Gibb D. Letter to the editor "Spinal injection: corticosteroids". Med J Aust 2 (1981) 318-319
21. Giles K.E., Finch P.M., Gee G., and Jacobs S. Letter to the editor. Med J Aust 1 (1982) 9-10
22. Goldstein N.P., McGuckin W.F., McKenzie B.F., and Mattox V.R. Experimental intrathecal administration of methylprednisolone acetate in multiple sclerosis. Trans Am Neurol Assoc 95 (1970) 243-244
23. Gonski A. Letter to the editor. Med J Aust 1 (1982) 9
24. Haynes G., Bailey M.K., Davis S., and Mahaffey J.E. Letter to the editor "Use of methylprednisolone in epidural analgesia". Arch Neurol 46 (1989) 1167-1168
25. Huygen F.J., de Bruijn A.G., De Bruin M.T., Groeneweg J.G., Klein J., and Zijlstra F.J. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm 11 (2002) 47-51
26. Ireland B.J. Letter to the editor. Med J Aust 1 (1982) 10-11
27. Jacobs D. Letter to the editor "Intrathecal and epidural/extradural injection of Depo Medrol". Med J Aust 2 (1981) 301
28. Jänig W., and Baron R. Complex regional pain syndrome: mystery explained?. Lancet Neurol 2 (2003) 687-697
29. Jankovic J., and Lang A.E. Movement disorders: diagnosis and assessment. In: Bradley W.G., Daroff R.B., Fenichel G.M., and Jankovic J. (Eds). Neurology in clinical practice. Principles of diagnosis and management. 4th ed. vol. 1 (2004), Butterworth, Philadelphia 305-306
30. Kemler M.A., Barendse G.A., van Kleef M., de Vet H.C., Rijks C.P., Furnée C.A., et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med 343 (2000) 618-624
31. Kingery W.S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 73 (1997) 123-139
32. Koszdin K.L., Shen D.D., and Bernards C.M. Spinal cord bioavailability of methylprednisolone after intravenous and intrathecal administration: the role of P-glycoprotein. Anesthesiology 92 (2000) 156-163
33. Kotani N., Kushikata T., Hashimoto H., Kimura F., Muraoka M., Yodono M., et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 343 (2000) 1514-1519
34. Marchand F., Perretti M., and McMahon S.B. Role of the immune system in chronic pain. Nat Rev Neurosci 6 (2005) 521-532
35. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1 (1975) 277-299
36. Merskey H., and Bogduk N. Relatively generalized syndromes. In: Merskey H., and Bogduk N. (Eds). Classification of chronic pain. Description of chronic pain syndromes and definitions of pain terms (1994), IASP Press, Seattle 40-43
37. Moalem G., and Tracey D.J. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 51 (2006) 240-264
38. Munts A.G., Zijlstra F.J., Nibbering P.H., Daha M.R., Marinus J., Dahan A., et al. Analysis of cerebrospinal fluid inflammatory mediators in chronic complex regional pain syndrome related dystonia. Clin J Pain 24 (2008) 30-34
39. Munts A.G., Voormolen J.H., Marinus J., Delhaas E.M., and van Hilten J.J. Postdural puncture headache in complex regional pain syndrome: a retrospective observational study. Pain Med (2009) 10.1111/j.1526-4637.2009.00727.x
40. Nelson D.A., Vates T.S., and Thomas R.B. Complications from intrathecal steroid therapy in patients with multiple sclerosis. Acta Neurol Scand 49 (1973) 176-188
41. Nelson D.A. Arachnoiditis from intrathecally given corticosteroids in the treatment of multiple sclerosis. Arch Neurol 33 (1976) 373
42. Nelson D.A. Letter to the editor "Methylprednisolone acetate". Arch Neurol 36 (1979) 661-662
43. Nelson D.A. Dangers from methylprednisolone acetate therapy by intraspinal injection. Arch Neurol 45 (1988) 804-806
44. Nelson D.A. Reply to the letter to the editor "Dangers from methylprednisolone acetate therapy by intraspinal injection". Arch Neurol 46 (1989) 721-722
45. Nelson D.A. Reply to the letter to the editor "Perceived dangers from intraspinal steroid injections". Arch Neurol 46 (1989) 720-721
46. Nelson D.A. Reply to the letter to the editor "Safety of intrathecal steroids in multiple sclerosis". Arch Neurol 46 (1989) 718-719
47. Rhen T., and Cidlowski J.A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 353 (2005) 1711-1723
48. Rivera V.M. Letter to the editor "Safety of intrathecal steroids in multiple sclerosis". Arch Neurol 46 (1989) 718
49. Roberts M., Sheppard G.L., and McCormick R.C. Tuberculous meningitis after intrathecally administered methylprednisolone acetate. JAMA 200 (1967) 894-896
50. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., et al. Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410 (2001) 471-475
51. Scholz J., and Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10 (2007) 1361-1368
52. Sehgal A.D., Tweed D.C., Gardner W.J., and Foote M.K. Laboratory studies after intrathecal corticosteroids: determination of corticosteroids in plasma and cerebrospinal fluid. Arch Neurol 9 (1963) 64-68
53. Shealy C.N. Dangers of spinal injections without proper diagnosis. JAMA 197 (1966) 1104-1106
54. Turnbull D.K., and Shepherd D.B. Post-dural puncture headache: pathogenesis, prevention and treatment. Br J Anaesth 91 (2003) 718-729
55. van Hilten J.J., Blumberg H., and Schwartzman R.J. Factor IV: movement disorders and dystrophy-Pathophysiology and measurement. In: Wilson P., Stanton-Hicks M., and Harden R.N. (Eds). CRPS: current diagnosis and therapy, progress in pain research and management vol. 32 (2005), IASP Press, Seattle 119-137
56. Veldman P.H., Reynen H.M., Arntz I.E., and Goris R.J. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 342 (1993) 1012-1016
57. Weisz G.M. Letter to the editor. Med J Aust 1 (1982) 9
58. Wilkinson H. Letter to the editor "Dangers from methylprednisolone acetate therapy by intraspinal injection". Arch Neurol 46 (1989) 721
59. Wilkinson H.A. Intrathecal Depo-Medrol: a literature review. Clin J Pain 8 (1992) 49-56
60. Wilkinson H.A. Reply to comment on "Intrathecal Depo-Medrol". Clin J Pain 8 (1992) 58
61. Woolf C.J., and Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353 (1999) 1959-1964
62. Woolf C.J., and Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 288 (2000) 1765-1769